Embla Medical hf
CSE:EMBLA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Embla Medical hf
CSE:EMBLA
|
IS |
Multiples-Based Value
The
Multiples-Based Value for
Embla Medical hf (EMBLA)
under the Base Case is
37.11
DKK.
Compared with the current market price of 26.4 DKK, the stock appears
Undervalued by 29%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
EMBLA Competitors Multiples
Embla Medical hf Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IS |
|
Embla Medical hf
CSE:EMBLA
|
11.3B DKK | 1.9 | 21.4 | 11.4 | 16.9 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
178.3B USD | 4 | 27.3 | 15.7 | 21.5 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
163.7B USD | 16.3 | 57.3 | 43.4 | 53.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.7B USD | 5 | 38.7 | 19.8 | 24 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
111.2B USD | 3.1 | 24.1 | 13.3 | 19.4 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
93.1B USD | 4.6 | 32.1 | 19.1 | 25.6 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
40.9B EUR | 1.8 | 19.4 | 10.9 | 15.4 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
46.5B USD | 7.7 | 43.4 | 23.8 | 26.1 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
44.8B USD | 10.4 | 42.3 | 30 | 33.2 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.8B USD | 2 | 25.5 | 10.1 | 17 | |
| US |
|
Resmed Inc
NYSE:RMD
|
32.7B USD | 6.1 | 22 | 15.5 | 17.2 |